NCT05093205View on ClinicalTrials.gov

STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

July 6, 2022

Study Completion Date

July 6, 2022

Conditions
Healthy Adults
Interventions
DRUG

PF-06882961

Tablets

DRUG

Atorvastatin

Tablets

DRUG

Midazolam

Syrup

DRUG

Levonorgestrel & Ethinyl Estradiol

Tablet

Trial Locations (1)

92801

Anaheim Clinical Trials, LLC, Anaheim

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05093205 - STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS | Biotech Hunter | Biotech Hunter